{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:55:37Z","timestamp":1788972937711,"version":"build-2803163510"},"reference-count":181,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundamental Research Funds for the Central Universities, Peking Union Medical College","award":["3332025015"],"award-info":[{"award-number":["3332025015"]}]},{"award":["3332025015"],"award-info":[{"award-number":["3332025015"]}],"id":[{"id":"https:\/\/ror.org\/02drdmm93","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Beijing Research Ward Excellence Program","award":["BRWEP2024W034010103"],"award-info":[{"award-number":["BRWEP2024W034010103"]}]},{"name":"Beijing Natural Science Foundation","award":["L232016"],"award-info":[{"award-number":["L232016"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Although nanomedicine has enabled significant advances in drug delivery, the clinical translation of conventional synthetic nanocarriers is limited by immune clearance, non-specific biodistribution, and gastrointestinal instability. This poses major challenges for therapy targeting the intestines. Cell membrane-coated nanotechnology (CMCT) and membrane vesicle-based systems have emerged as biomimetic platforms integrating synthetic nanomaterials with naturally derived biological interfaces. These biohybrid systems inherit biological functions originating from cells, including immune evasion, prolonged circulation, lesion homing, and microenvironment-responsive interactions, through the direct transfer of intact membrane components. This review summarizes recent advances in CMCT and membrane vesicle-based strategies for intestinal drug delivery. It covers fabrication methodologies, programmable manufacturing approaches, and functional regulation enabled by diverse membrane sources and hybrid engineering designs. Applications in inflammatory bowel disease, colorectal cancer, and intestinal infections are highlighted, emphasizing key therapeutic mechanisms, such as targeting inflammation, neutralizing toxins, modulating the immune system, and regulating the microbiome. We also discuss the major challenges of translation, such as preserving membrane and coating integrity, ensuring oral stability, achieving batch reproducibility, and ensuring biosafety. Overall, this review establishes a conceptual and engineering framework to guide the transition of membrane-based nanocarriers from passive biomimicry to adaptive, clinically translatable intestinal delivery systems.<\/jats:p>","DOI":"10.3390\/pharmaceutics18050534","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:46:11Z","timestamp":1777455971000},"page":"534","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Advances of Cell Membrane-Coated Nanotechnology and Membrane Vesicles in Intestinal Targeted Drug Delivery Systems"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7605-0379","authenticated-orcid":false,"given":"Rou","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China"},{"name":"Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujun","family":"Zeng","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9222-7327","authenticated-orcid":false,"given":"Chengzhen","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyekai","family":"Tuerheng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7579-0592","authenticated-orcid":false,"given":"Ziqi","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2265-7092","authenticated-orcid":false,"given":"Kun","family":"He","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9430-9874","authenticated-orcid":false,"given":"Dong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China"},{"name":"Department of Gastroenterology, People\u2019s Hospital of Xizang Autonomous Region, Lhasa 850000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.7150\/thno.115723","article-title":"Engineered RAP-anchored copper-escorting liposomes for FDX1-targeted cuproptosis in glioblastoma therapy","volume":"15","author":"Liu","year":"2025","journal-title":"Theranostics"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41565-025-01954-9","article-title":"A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles","volume":"20","author":"Chen","year":"2025","journal-title":"Nature Nanotechnol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jconrel.2025.02.018","article-title":"Multidrug micelles and sonopermeation for chemotherapy co-delivery to brain tumors","volume":"380","author":"Dasgupta","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1021\/ar200105p","article-title":"Liposomes: From a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine","volume":"44","author":"Kostarelos","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"113851","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s40265-017-0741-1","article-title":"Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma","volume":"77","author":"Lamb","year":"2017","journal-title":"Drugs"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101103","DOI":"10.1016\/j.nanoso.2024.101103","article-title":"Recent advances in nanomaterial-based drug delivery systems","volume":"37","author":"Jadhav","year":"2024","journal-title":"Nano-Struct. Nano-Objects"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2022.08.001","article-title":"Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches","volume":"351","author":"Ashrafizadeh","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"De Matteis, V. (2017). Exposure to Inorganic Nanoparticles: Routes of Entry, Immune Response, Biodistribution and In Vitro\/In Vivo Toxicity Evaluation. Toxics, 5.","DOI":"10.3390\/toxics5040029"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: Recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1573403X10666140914160554","article-title":"Nanoparticles and the mononuclear phagocyte system: Pharmacokinetics and applications for inflammatory diseases","volume":"10","author":"Song","year":"2014","journal-title":"Curr. Rheumatol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1039\/D2BM00181K","article-title":"Nanoparticle based medicines: Approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation","volume":"10","author":"Mills","year":"2022","journal-title":"Biomater. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Homayun, B., Lin, X., and Choi, H.-J. (2019). Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11030129"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2016.07.051","article-title":"Role of nanoparticle size, shape and surface chemistry in oral drug delivery","volume":"238","author":"Banerjee","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"13044","DOI":"10.1021\/acsnano.3c02403","article-title":"Mechanisms of Nanoparticle Transport across Intestinal Tissue: An Oral Delivery Perspective","volume":"17","author":"Ejazi","year":"2023","journal-title":"ACS Nano"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1706759","DOI":"10.1002\/adma.201706759","article-title":"Cell Membrane Coating Nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101716","DOI":"10.1016\/j.mtbio.2025.101716","article-title":"Improving tumor treatment: Cell membrane-coated nanoparticles for targeted therapies","volume":"32","author":"Marchal","year":"2025","journal-title":"Mater. Today Bio"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"26296","DOI":"10.1021\/acsnano.5c04463","article-title":"Tissue-Resident Macrophage Membrane-Coated Nanomedicine for Targeted Tumor Therapy","volume":"19","author":"Su","year":"2025","journal-title":"ACS Nano"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11517","DOI":"10.1021\/acsnano.4c16280","article-title":"Engineered Cell Membrane Coating Technologies for Biomedical Applications: From Nanoscale to Macroscale","volume":"19","author":"An","year":"2025","journal-title":"ACS Nano"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15668","DOI":"10.1021\/acsnano.4c18153","article-title":"Chimeric Antigen Receptor-Engineered Cell Membrane-Coated Nanoparticles Promote Dual-Targeted mRNA-Based Cancer Gene Therapy","volume":"19","author":"Lei","year":"2025","journal-title":"ACS Nano"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"122869","DOI":"10.1016\/j.biomaterials.2024.122869","article-title":"Engineering cell membrane-camouflaged COF-based nanosatellite for enhanced tumor-targeted photothermal chemoimmunotherapy","volume":"314","author":"Lin","year":"2024","journal-title":"Biomaterials"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2406143","DOI":"10.1002\/adma.202406143","article-title":"NIR-II AIE Luminogen-Based Erythrocyte-Like Nanoparticles with Granuloma-Targeting and Self-Oxygenation Characteristics for Combined Phototherapy of Tuberculosis","volume":"36","author":"Wang","year":"2024","journal-title":"Adv. Mater."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e2311128","DOI":"10.1002\/smll.202311128","article-title":"Platelet Membrane-Coated Curcumin-PLGA Nanoparticles Promote Astrocyte-Neuron Transdifferentiation for Intracerebral Hemorrhage Treatment","volume":"20","author":"Xu","year":"2024","journal-title":"Small"},{"key":"ref_26","first-page":"45","article-title":"Stromal-platelet membrane-inspired nanoparticles (SPIN) for targeted heart repair","volume":"53","author":"He","year":"2025","journal-title":"Bioact. Mater."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1021\/acsnano.7b09041","article-title":"Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination","volume":"12","author":"Yang","year":"2018","journal-title":"ACS Nano"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"114940","DOI":"10.1016\/j.colsurfb.2025.114940","article-title":"Cancer cell membrane-coated quercetin-MXene-Au nanoparticles for smart drug delivery and enhanced photothermal therapy","volume":"255","author":"Elbeltagi","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"26614","DOI":"10.1021\/acsnano.4c04814","article-title":"Platelet and Erythrocyte Membranes Coassembled Biomimetic Nanoparticles for Heart Failure Treatment","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"19756","DOI":"10.1021\/acsnano.1c07180","article-title":"Cancer-Erythrocyte Hybrid Membrane-Camouflaged Magnetic Nanoparticles with Enhanced Photothermal-Immunotherapy for Ovarian Cancer","volume":"15","author":"Xiong","year":"2021","journal-title":"ACS Nano"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1606209","DOI":"10.1002\/adma.201606209","article-title":"Erythrocyte-Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization","volume":"29","author":"Dehaini","year":"2017","journal-title":"Adv. Mater."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e2411261","DOI":"10.1002\/advs.202411261","article-title":"Hybrid Cell Membrane-Engineered Nanocarrier for Triple-Action Strategy to Address Pseudomonas aeruginosa Infection","volume":"12","author":"Zhang","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e2006484","DOI":"10.1002\/smll.202006484","article-title":"Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy","volume":"17","author":"Oroojalian","year":"2021","journal-title":"Small"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e1901255","DOI":"10.1002\/adma.201901255","article-title":"Biomimetic Nanotechnology toward Personalized Vaccines","volume":"32","author":"Zhou","year":"2019","journal-title":"Adv. Mater."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.addr.2004.07.001","article-title":"Intelligent therapeutics: Biomimetic systems and nanotechnology in drug delivery","volume":"56","author":"Peppas","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrd3499","article-title":"Bio-inspired, bioengineered and biomimetic drug delivery carriers","volume":"10","author":"Yoo","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrm2328","article-title":"Membrane recognition by phospholipid-binding domains","volume":"9","author":"Lemmon","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.biophys.33.110502.133337","article-title":"Membrane-Protein Interactions in Cell Signaling and Membrane Trafficking","volume":"34","author":"Cho","year":"2005","journal-title":"Annu. Rev. Biophys."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"F89","DOI":"10.1083\/jcb.150.2.F89","article-title":"The evolution of cell adhesion","volume":"150","author":"Hynes","year":"2000","journal-title":"J. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/btm2.10004","article-title":"Biomimetic strategies for targeted nanoparticle delivery","volume":"1","author":"Dehaini","year":"2016","journal-title":"Bioeng. Transl. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1021\/nn500512x","article-title":"Internalization of red blood cell-mimicking hydrogel capsules with pH-triggered shape responses","volume":"8","author":"Kozlovskaya","year":"2014","journal-title":"ACS Nano"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.biomaterials.2017.02.041","article-title":"Cell membrane-derived nanomaterials for biomedical applications","volume":"128","author":"Fang","year":"2017","journal-title":"Biomaterials"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a Marker of Self on Red Blood Cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/adhm.201200138","article-title":"Erythrocyte-inspired delivery systems","volume":"1","author":"Hu","year":"2012","journal-title":"Adv. Healthc. Mater."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"19228","DOI":"10.1016\/S0021-9258(19)47291-8","article-title":"Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex","volume":"264","author":"Sims","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","article-title":"Platelet-collagen interaction: Is GPVI the central receptor?","volume":"102","author":"Nieswandt","year":"2003","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1182\/blood-2004-08-2980","article-title":"Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia","volume":"105","author":"Olsson","year":"2005","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"863","DOI":"10.7150\/thno.11852","article-title":"Cell or cell membrane-based drug delivery systems","volume":"5","author":"Tan","year":"2015","journal-title":"Theranostics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/nsr\/nwz037","article-title":"Cell membrane-covered nanoparticles as biomaterials","volume":"6","author":"Xuan","year":"2019","journal-title":"Natl. Sci. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2400012","DOI":"10.1002\/anbr.202400012","article-title":"Cell Membrane-Coated Nanoparticles: A New Frontier in Immunomodulation","volume":"4","author":"Desai","year":"2024","journal-title":"Adv. NanoBiomed Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e2200289","DOI":"10.1002\/smtd.202200289","article-title":"Macrophage Cell Membrane-Cloaked Nanoplatforms for Biomedical Applications","volume":"6","author":"Lopes","year":"2022","journal-title":"Small Methods"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"20230164","DOI":"10.1002\/EXP.20230164","article-title":"Innovative utilization of cell membrane-coated nanoparticles in precision cancer therapy","volume":"4","author":"He","year":"2024","journal-title":"Exploration"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e1707112","DOI":"10.1002\/adma.201707112","article-title":"PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy","volume":"30","author":"Zhang","year":"2018","journal-title":"Adv. Mater."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12951-022-01266-3","article-title":"Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy","volume":"20","author":"Chen","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2000291","DOI":"10.1002\/smtd.202000291","article-title":"Mimovirus vesicle-based biological orthogonal reaction for cancer diagnosis","volume":"4","author":"Ren","year":"2020","journal-title":"Small Methods"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"12794","DOI":"10.1007\/s10853-019-03788-y","article-title":"Cancer cell membrane as gate keeper of mesoporous silica nanoparticles and photothermal-triggered membrane fusion to release the encapsulated anticancer drug","volume":"54","author":"Ding","year":"2019","journal-title":"J. Mater. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Wang, F., Deng, Y., Yu, L., Zhou, A., Wang, J., Jia, J., Li, N., Ding, F., Lian, W., and Liu, Q. (2022). A Macrophage Membrane-Polymer Hybrid Biomimetic Nanoplatform for Therapeutic Delivery of Somatostatin Peptide to Chronic Pancreatitis. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14112341"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"100004","DOI":"10.1016\/j.vesic.2022.100004","article-title":"Cell-derived nanovesicles prepared by membrane extrusion are good substitutes for natural extracellular vesicles","volume":"1","author":"Wen","year":"2022","journal-title":"Extracell. Vesicle"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jconrel.2021.05.031","article-title":"Active stealth and self-positioning biomimetic vehicles achieved effective antitumor therapy","volume":"335","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.01.036","article-title":"Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy","volume":"105","author":"Xu","year":"2020","journal-title":"Acta Biomater."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1039\/C3NR06371B","article-title":"Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles","volume":"6","author":"Luk","year":"2014","journal-title":"Nanoscale"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1021\/acsnano.7b00133","article-title":"Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy","volume":"11","author":"Rao","year":"2017","journal-title":"ACS Nano"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1021\/acs.nanolett.9b02841","article-title":"Microfluidic Sonication To Assemble Exosome Membrane-Coated Nanoparticles for Immune Evasion-Mediated Targeting","volume":"19","author":"Liu","year":"2019","journal-title":"Nano Lett."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Fondaj, D., Arduino, I., Lopedota, A.A., Denora, N., and Iacobazzi, R.M. (2023). Exploring the Microfluidic Production of Biomimetic Hybrid Nanoparticles and Their Pharmaceutical Applications. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15071953"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"11374","DOI":"10.1039\/c3nr01541f","article-title":"Cell-derived vesicles as a bioplatform for the encapsulation of theranostic nanomaterials","volume":"5","author":"Silva","year":"2013","journal-title":"Nanoscale"},{"key":"ref_68","first-page":"49","article-title":"Cell membrane coated nanoparticles for biomedical applications","volume":"3","author":"Nemati","year":"2022","journal-title":"Adv. Appl. Nano-Bio Technol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"116951","DOI":"10.1016\/j.biopha.2024.116951","article-title":"Recent advances in biomimetic cell membrane-camouflaged nanoparticles for cancer therapy","volume":"177","author":"Alimohammadvand","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e2001808","DOI":"10.1002\/adma.202001808","article-title":"Engineered Cell-Membrane-Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity","volume":"32","author":"Jiang","year":"2020","journal-title":"Adv. Mater."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12951-024-02587-1","article-title":"Microfluidics-enabled mesenchymal stem cell derived Neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson\u2019s Disease","volume":"22","author":"Lei","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"100633","DOI":"10.1016\/j.mtbio.2023.100633","article-title":"Cell membrane-coated nanomaterials for cancer therapy","volume":"20","author":"Zeng","year":"2023","journal-title":"Mater. Today Bio"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2003559","DOI":"10.1002\/adfm.202003559","article-title":"Recent advances of cell membrane-coated nanomaterials for biomedical applications","volume":"30","author":"Liu","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Kim, Y.-A., Lee, M.H., Sohn, H.S., and Kim, H.Y. (2026). From Circulation to Regeneration: Blood Cell Membrane-Coated Nanoparticles as Drug Delivery Platform for Immune-Regenerative Therapy. Pharmaceutics, 18.","DOI":"10.3390\/pharmaceutics18010066"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.actbio.2017.06.035","article-title":"Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy","volume":"59","author":"Ren","year":"2017","journal-title":"Acta Biomater."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Lazareva, P., Chulanov, V., Kostyushev, D., and Abakumov, M. (2025). In Vivo Behavior of Biomimetic Nanoparticles: Strategies for Clearance Avoidance, Targeting, and Functional Delivery. Molecules, 30.","DOI":"10.3390\/molecules30224487"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"102343","DOI":"10.1016\/j.mtbio.2025.102343","article-title":"Cell membrane biomimetic nanoplatforms: A new strategy for immune escape and precision targeted therapy","volume":"35","author":"Feng","year":"2025","journal-title":"Mater. Today Bio"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1039\/c3nr03064d","article-title":"Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles","volume":"5","author":"Fang","year":"2013","journal-title":"Nanoscale"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1073\/pnas.1701746114","article-title":"Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease","volume":"114","author":"Pishesha","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nnano.2013.54","article-title":"A biomimetic nanosponge that absorbs pore-forming toxins","volume":"8","author":"Hu","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nnano.2013.254","article-title":"Nanoparticle-detained toxins for safe and effective vaccination","volume":"8","author":"Hu","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"ref_82","first-page":"132","article-title":"Erythrocytes Nanoparticle Delivery: A Boon for Targeting Tumor","volume":"14","author":"Siddique","year":"2023","journal-title":"Adv. Pharm. Bull."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"0011","DOI":"10.1038\/s41551-016-0011","article-title":"In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy","volume":"1","author":"Wang","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biomaterials.2015.10.046","article-title":"Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles","volume":"76","author":"Li","year":"2016","journal-title":"Biomaterials"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"18430","DOI":"10.1021\/acsnano.2c06584","article-title":"Engineered Platelet Microparticle-Membrane Camouflaged Nanoparticles for Targeting the Golgi Apparatus of Synovial Fibroblasts to Attenuate Rheumatoid Arthritis","volume":"16","author":"Deng","year":"2022","journal-title":"ACS Nano"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Zhang, R., Mei, R., Liang, B., Zhang, X., Zhang, T., Luo, J., Zhang, J., Pan, Q., and Yan, Y. (2025). Bionic platelet membrane-coated rutin nanoparticles attenuate ulcerative colitis by suppressing platelet-mediated macrophage inflammation. Drug Deliv. Transl. Res.","DOI":"10.1007\/s13346-025-02028-y"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1073\/pnas.1714267114","article-title":"Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management","volume":"114","author":"Thamphiwatana","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7150\/thno.47841","article-title":"Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1021\/acs.nanolett.1c00818","article-title":"Tumor-Associated-Macrophage-Membrane-Coated Nanoparticles for Improved Photodynamic Immunotherapy","volume":"21","author":"Chen","year":"2021","journal-title":"Nano Lett."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.7150\/thno.114855","article-title":"Transdermal microneedle integrating a biomimetic self-enhancing Fenton reaction nano-reactor for alleviating rheumatoid arthritis by inflammatory microenvironment remodeling","volume":"15","author":"Gao","year":"2025","journal-title":"Theranostics"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"042003","DOI":"10.1088\/1748-605X\/ad4aaa","article-title":"Macrophage membrane-coated nanoparticles for the treatment of infectious diseases","volume":"19","author":"Wang","year":"2024","journal-title":"Biomed. Mater."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12951-025-03921-x","article-title":"Macrophage membrane-coated nanoparticles in inflammatory diseases: From bioinspired design to translational potential","volume":"24","author":"Hou","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"39805","DOI":"10.1021\/acsnano.5c12658","article-title":"Natural Macrophage Membrane-Coated Nanoparticles as a Multifaceted Sepsis Therapeutic to Sequester Inflammatory and Toxic Mediators","volume":"19","author":"Hoffman","year":"2025","journal-title":"ACS Nano"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/nl500618u","article-title":"Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery","volume":"14","author":"Fang","year":"2014","journal-title":"Nano Lett."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41375-021-01432-w","article-title":"Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapy","volume":"36","author":"Johnson","year":"2021","journal-title":"Leukemia"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1038\/s41467-025-59977-8","article-title":"Neoantigen enriched biomimetic nanovaccine for personalized cancer immunotherapy","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12951-021-01202-x","article-title":"Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer","volume":"19","author":"Chen","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/acs.nanolett.9b03817","article-title":"Cancer-Cell-Membrane-Coated Nanoparticles with a Yolk-Shell Structure Augment Cancer Chemotherapy","volume":"20","author":"Nie","year":"2019","journal-title":"Nano Lett."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"101275","DOI":"10.1016\/j.mtbio.2024.101275","article-title":"Cancer cell membrane-coated siRNA-Decorated Au\/MnO2 nanosensitizers for synergistically enhanced radio-immunotherapy of breast cancer","volume":"29","author":"Wang","year":"2024","journal-title":"Mater. Today Bio"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1021\/nl401376w","article-title":"Reconstructed stem cell nanoghosts: A natural tumor targeting platform","volume":"13","author":"Bronshtein","year":"2013","journal-title":"Nano Lett."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1021\/acsnano.5b07172","article-title":"Human Induced Pluripotent Stem Cells for Tumor Targeted Delivery of Gold Nanorods and Enhanced Photothermal Therapy","volume":"10","author":"Liu","year":"2016","journal-title":"ACS Nano"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1002\/adma.201401550","article-title":"Stem cells loaded with nanoparticles as a drug carrier for in vivo breast cancer therapy","volume":"26","author":"Cao","year":"2014","journal-title":"Adv. Mater."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"34252","DOI":"10.1021\/acsami.6b12865","article-title":"Stem-Cell-Membrane Camouflaging on Near-Infrared Photoactivated Upconversion Nanoarchitectures for in Vivo Remote-Controlled Photodynamic Therapy","volume":"8","author":"Gao","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1002\/smll.201600624","article-title":"Stem Cell Membrane-Coated Nanogels for Highly Efficient In Vivo Tumor Targeted Drug Delivery","volume":"12","author":"Gao","year":"2016","journal-title":"Small"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"065010","DOI":"10.1088\/1748-605X\/ae0bda","article-title":"Stem cell membrane-coated rough mesoporous silica nanoparticles for enhanced osteogenic differentiation and bone repair via dexamethasone delivery","volume":"20","author":"Chen","year":"2025","journal-title":"Biomed. Mater."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"113625","DOI":"10.1016\/j.jconrel.2025.113625","article-title":"Curcumin-PLGA NPs coated with targeting biomimetic personalized stem cell membranes for osteoarthritis therapy","volume":"381","author":"Lee","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"eabg3217","DOI":"10.1126\/sciadv.abg3217","article-title":"Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy","volume":"7","author":"Ho","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12951-026-04041-w","article-title":"Biomimetic nanovesicles decorated with chemotactic and target membrane proteins for lupus nephritis treatment","volume":"24","author":"Gan","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"ref_109","first-page":"267","article-title":"Biomimetic universal CAR-mesenchymal stem cell nanohybrids for anti-tumor therapy","volume":"57","author":"Yang","year":"2025","journal-title":"Bioact. Mater."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"123725","DOI":"10.1016\/j.biomaterials.2025.123725","article-title":"Engineered bacterial outer membrane vesicles enhanced tumor immunotherapy through remodeling tumor stroma and targeted delivery of CD73 siRNA","volume":"327","author":"Cheng","year":"2026","journal-title":"Biomaterials"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"33937","DOI":"10.1021\/acsnano.4c07992","article-title":"Hybrid Nanoparticle Engineered with Transforming Growth Factor-\u03b21-Overexpressed Extracellular Vesicle and Cartilage-Targeted Anti-Inflammatory Liposome for Osteoarthritis","volume":"18","author":"Kim","year":"2024","journal-title":"ACS Nano"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e2306675","DOI":"10.1002\/advs.202306675","article-title":"Hybrid Membrane-Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer\u2019s Disease","volume":"11","author":"Lin","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12951-024-02619-w","article-title":"Bacterial outer membrane vesicle-cancer cell hybrid membrane-coated nanoparticles for sonodynamic therapy in the treatment of breast cancer bone metastasis","volume":"22","author":"Wang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"113795","DOI":"10.1016\/j.jconrel.2025.113795","article-title":"Hybrid membrane-coated Cyclosporine A nanocrystals preventing secondary brain injury via alleviating neuroinflammatory and oxidative stress","volume":"383","author":"Zhou","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e202404889","DOI":"10.1002\/anie.202404889","article-title":"Engineered Cellular Vesicles Displaying Glycosylated Nanobodies for Cancer Immunotherapy","volume":"63","author":"Wu","year":"2024","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1021\/acsnano.2c11965","article-title":"Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles","volume":"17","author":"Nguyen","year":"2023","journal-title":"ACS Nano"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1039\/D5BM00660K","article-title":"Advances in cell membrane-coated nanoparticles: Multifunctional platforms for targeted drug delivery, precision phototherapy, and enhanced immunotherapy","volume":"13","author":"Sultana","year":"2025","journal-title":"Biomater. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41392-025-02198-8","article-title":"Platelets and diseases: Signal transduction and advances in targeted therapy","volume":"10","author":"Tian","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cardiores.2003.11.036","article-title":"Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium","volume":"61","author":"Gawaz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.nano.2015.09.005","article-title":"Platelet mimicry: The emperor\u2019s new clothes?","volume":"12","author":"Moghimi","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"217044","DOI":"10.1016\/j.canlet.2024.217044","article-title":"The use of platelets as a clinical tool in oncology: Opportunities and challenges","volume":"607","author":"Bravaccini","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nri1375","article-title":"Adhesion mechanisms regulating the migration of monocytes","volume":"4","author":"Imhof","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","article-title":"Macrophage cell membrane-based nanoparticles: A new promising biomimetic platform for targeted delivery and treatment","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/acs.bioconjchem.6b00569","article-title":"Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles","volume":"28","author":"Kroll","year":"2016","journal-title":"Bioconjug Chem."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Lin, J., Li, W., Aboushanab, A.R., and Sun, J. (2025). Cancer Cell Membrane-Coated NPs as a Biomimetic Strategy for Precision Tumor Therapy. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17101322"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.1039\/D4RA01026D","article-title":"Cancer cell membrane-coated nanoparticles: A promising anti-tumor bionic platform","volume":"14","author":"Guo","year":"2024","journal-title":"RSC Adv."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/IJN.S346044","article-title":"Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy","volume":"17","author":"Zhao","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"213456","DOI":"10.1016\/j.bioadv.2023.213456","article-title":"Erythrocyte-cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer","volume":"151","author":"Rezaei","year":"2023","journal-title":"Biomater. Adv."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4252\/wjsc.v13.i6.619","article-title":"Biological, chemical and mechanical factors regulating migration and homing of mesenchymal stem cells","volume":"13","author":"Szydlak","year":"2021","journal-title":"World J. Stem Cells"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02256058","article-title":"Characterization and functionality of cell surface molecules on human mesenchymal stem cells","volume":"10","author":"Majumdar","year":"2003","journal-title":"J. Biomed. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"100377","DOI":"10.1016\/j.mtbio.2022.100377","article-title":"Stem cell membrane-camouflaged targeted delivery system in tumor","volume":"16","author":"Zhang","year":"2022","journal-title":"Mater. Today Bio"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1021\/acsnano.8b00553","article-title":"Mesenchymal Stem Cell\/Red Blood Cell-Inspired Nanoparticle Therapy in Mice with Carbon Tetrachloride-Induced Acute Liver Failure","volume":"12","author":"Liang","year":"2018","journal-title":"ACS Nano"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12951-023-02119-3","article-title":"Bioinspired nanovesicles released from injectable hydrogels facilitate diabetic wound healing by regulating macrophage polarization and endothelial cell dysfunction","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jconrel.2022.06.026","article-title":"Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics","volume":"348","author":"Khosravi","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.05.028","article-title":"Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy","volume":"112","author":"Chen","year":"2020","journal-title":"Acta Biomater."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e2303617","DOI":"10.1002\/advs.202303617","article-title":"Beyond Extracellular Vesicles: Hybrid Membrane Nanovesicles as Emerging Advanced Tools for Biomedical Applications","volume":"10","author":"Sun","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s40843-025-3740-y","article-title":"Engineering revolution of cell membrane-biomimetic nanoparticles: From hybridization strategy innovation to microfluidics-enabled precision fabrication","volume":"69","author":"Liu","year":"2026","journal-title":"Sci. China Mater."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"112067","DOI":"10.1016\/j.matdes.2023.112067","article-title":"Biomembrane and metal nanostructures for cancer theranostics: The state of the art in the combination of organic and inorganic chemistry","volume":"231","author":"Zhang","year":"2023","journal-title":"Mater. Des."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"107844","DOI":"10.1016\/j.phrs.2025.107844","article-title":"Engineered nanomaterials for overcoming multifaceted gastrointestinal barriers: Toward precision oral delivery of therapeutics","volume":"218","author":"Liu","year":"2025","journal-title":"Pharmacol. Res."},{"key":"ref_144","first-page":"368","article-title":"Work disability in inflammatory bowel disease patients 10 years after disease onset: Results from the IBSEN Study","volume":"62","author":"Moum","year":"2012","journal-title":"Gut"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.7150\/thno.48448","article-title":"Amelioration of ulcerative colitis via inflammatory regulation by macrophage-biomimetic nanomedicine","volume":"10","author":"Sun","year":"2020","journal-title":"Theranostics"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000519363","article-title":"Macrophage-Biomimetic Nanoparticles Ameliorate Ulcerative Colitis through Reducing Inflammatory Factors Expression","volume":"14","author":"Li","year":"2021","journal-title":"J. Innate Immun."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1021\/acsanm.2c04615","article-title":"Neutrophil Membrane-Coated Mesoporous Silica Nanoparticles Loaded with Hydrocortisone Alleviate DSS-Induced Colitis in Mice","volume":"6","author":"Wang","year":"2023","journal-title":"ACS Appl. Nano Mater."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"102139","DOI":"10.1016\/j.nantod.2023.102139","article-title":"Platelet-inspired nanomedicine targeting activated neutrophils to alleviate ulcerative colitis by free radicals scavenging and controlled neutrophil swarming","volume":"54","author":"Yan","year":"2024","journal-title":"Nano Today"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"14581","DOI":"10.1039\/C7NR04734G","article-title":"Engineered biomimetic nanovesicles show intrinsic anti-inflammatory properties for the treatment of inflammatory bowel diseases","volume":"9","author":"Corbo","year":"2017","journal-title":"Nanoscale"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"15893","DOI":"10.1021\/acsnano.3c03959","article-title":"Capsulated Cellular Nanosponges for the Treatment of Experimental Inflammatory Bowel Disease","volume":"17","author":"Duan","year":"2023","journal-title":"ACS Nano"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1021\/acsami.1c21700","article-title":"Biomimetic MOF Nanoparticles Delivery of C-Dot Nanozyme and CRISPR\/Cas9 System for Site-Specific Treatment of Ulcerative Colitis","volume":"14","author":"Ma","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12951-025-03123-5","article-title":"Neutrophil-macrophage hybrid membrane-coated prussian blue nanozyme for ulcerative colitis treatment and mechanistic insights","volume":"23","author":"Hu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e70006","DOI":"10.1002\/btm2.70006","article-title":"Biomembrane-coated nanosystems as next-generation delivery systems for the treatment of gastrointestinal cancers","volume":"10","author":"Lopes","year":"2025","journal-title":"Bioeng. Transl. Med."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Qiu, Z., Liu, W., and Xu, S. (2025). Advances in the multifunctionality of cell membrane-encapsulated nanoparticles in the treatment of colorectal cancer. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1657722"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/s41467-021-22311-z","article-title":"Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors","volume":"12","author":"Bahmani","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jcis.2021.02.006","article-title":"Cell membrane camouflaged bismuth nanoparticles for targeted photothermal therapy of homotypic tumors","volume":"591","author":"Ren","year":"2021","journal-title":"J. Colloid Interface Sci."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1038\/s41467-022-33889-3","article-title":"Systematic design of cell membrane coating to improve tumor targeting of nanoparticles","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"100294","DOI":"10.1016\/j.mtbio.2022.100294","article-title":"Bioactive cytomembrane@poly(citrate-peptide)-miRNA365 nanoplatform with immune escape and homologous targeting for colon cancer therapy","volume":"15","author":"Zhang","year":"2022","journal-title":"Mater. Today Bio"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"10030","DOI":"10.1021\/acsami.1c22166","article-title":"Functionalized LbL Film for Localized Delivery of STAT3 siRNA and Oxaliplatin Combination to Treat Colon Cancer","volume":"14","author":"Janardhanam","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.omto.2022.12.002","article-title":"A cancer cell membrane coated, doxorubicin and microRNA co-encapsulated nanoplatform for colorectal cancer theranostics","volume":"28","author":"Zhu","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jcis.2023.01.068","article-title":"Design and synthesis of cancer-cell-membrane-camouflaged hemoporfin-Cu9S8 nanoagents for homotypic tumor-targeted photothermal-sonodynamic therapy","volume":"637","author":"Zhao","year":"2023","journal-title":"J. Colloid. Interface Sci."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"105237","DOI":"10.1016\/j.jddst.2023.105237","article-title":"Macrophage membrane-coated self-assembled curcumin nanoparticle missile for the treatment of colorectal cancer","volume":"91","author":"Liu","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41392-024-01859-4","article-title":"Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer","volume":"9","author":"Yang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_164","first-page":"20908","article-title":"Cancer Cell-Mimicking Prussian Blue Nanoplatform for Synergistic Mild Photothermal\/Chemotherapy via Heat Shock Protein Inhibition","volume":"16","author":"Wang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"100092","DOI":"10.1016\/j.celbio.2025.100092","article-title":"Biomimetic \u201cTrojan Horse\u201d nanoparticles with biotactic behavior toward tumor-associated bacteria for targeted therapy of colorectal cancer","volume":"1","author":"Wu","year":"2025","journal-title":"Cell Biomater."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.7150\/thno.81520","article-title":"Cell-membrane-coated nanoparticles for the fight against pathogenic bacteria, toxins, and inflammatory cytokines associated with sepsis","volume":"13","author":"Wang","year":"2023","journal-title":"Theranostics"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/jacs.5c00955","article-title":"Glycan-Modified Cellular Nanosponges for Enhanced Treatment of Cholera Toxin-Induced Secretory Diarrhea","volume":"147","author":"Han","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.biomaterials.2018.10.029","article-title":"Engineered nanoparticles disguised as macrophages for trapping lipopolysaccharide and preventing endotoxemia","volume":"189","author":"Shen","year":"2019","journal-title":"Biomaterials"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"113702","DOI":"10.1016\/j.jconrel.2025.113702","article-title":"Pathogen-targeting biomineralized bacterial outer membrane vesicles for eradicating both intracellular and extracellular Staphylococcus aureus","volume":"382","author":"Yang","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"100679","DOI":"10.1016\/j.mtbio.2023.100679","article-title":"Intracellular hydrogelation of macrophage conjugated probiotics for hitchhiking delivery and combined treatment of colitis","volume":"20","author":"Wang","year":"2023","journal-title":"Mater. Today Bio"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40168-025-02078-x","article-title":"Faecalibacterium prausnitzii-derived outer membrane vesicles reprogram gut microbiota metabolism to alleviate Porcine Epidemic Diarrhea Virus infection","volume":"13","author":"Xing","year":"2025","journal-title":"Microbiome"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"107277","DOI":"10.1016\/j.phrs.2024.107277","article-title":"Faecalibacterium prausnitzii-derived extracellular vesicles alleviate chronic colitis-related intestinal fibrosis by macrophage metabolic reprogramming","volume":"206","author":"Wang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s40820-019-0330-9","article-title":"Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications","volume":"11","author":"Liu","year":"2019","journal-title":"Nano-Micro Letters"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Borbolla, A., Garc\u00eda-Hevia, L., and Fanarraga, M.L. (2024). Cell Membrane-Coated Nanoparticles for Precision Medicine: A Comprehensive Review of Coating Techniques for Tissue-Specific Therapeutics. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202402.0117.v1"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1038\/s41467-021-26052-x","article-title":"Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","article-title":"Cell membrane-coated nanoparticles: A novel multifunctional biomimetic drug delivery system","volume":"13","author":"Liu","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biomaterials.2017.09.020","article-title":"Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery","volume":"147","author":"Parodi","year":"2017","journal-title":"Biomaterials"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Lemmens, G., Van Camp, A., Kourula, S., Vanuytsel, T., and Augustijns, P. (2021). Drug Disposition in the Lower Gastrointestinal Tract: Targeting and Monitoring. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020161"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jaci.2009.02.024","article-title":"T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma","volume":"123","author":"Chouiali","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mi.2013.30","article-title":"Microfold (M) cells: Important immunosurveillance posts in the intestinal epithelium","volume":"6","author":"Mabbott","year":"2013","journal-title":"Mucosal Immunol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"2100241","DOI":"10.1002\/adma.202100241","article-title":"Cell\/Bacteria-Based Bioactive Materials for Cancer Immune Modulation and Precision Therapy","volume":"33","author":"Pan","year":"2021","journal-title":"Adv. Mater."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/5\/534\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:12:59Z","timestamp":1777522379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/5\/534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":181,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["pharmaceutics18050534"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18050534","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}